Companies / South Korea
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
South Korea Announces Off-Patent Drug Price Cut
August 2006 | Market Trend AnalysisSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
South Korea's government has announced that the reimbursement price for brand name drugs will be immediately reduced by 20% upon patent expiry. The news comes after calls for greater disclosure concerning the planned positive list reimbursement scheme.